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Introduction
Thoracic surgery can cause severe postoperative pain that 
results from the surgical incisions, disrupted intercostal 
nerves, retracted ribs, chest wall inflammation, injured 
pulmonary parenchyma, and placement of chest tubes (1). 
The postoperative pain can adversely interfere with the 
respiratory function, performance, outcome and quality 
of life of patients (2). Uncontrolled postoperative pain 
can lead to respiratory compromise, resulting in increased 
morbidity and a prolonged hospital stay (3). Although 
thoracoscopic surgery reduces postoperative pain compared 
with open thoracotomy, patients can also experience 
moderate to severe pain, especially during the first few 
hours after thoracoscopic surgery (4,5). The analgesic 
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options for postoperative pain control in thoracic surgery 
include thoracic epidural anesthesia, thoracic paravertebral 
blockade, intravenous patient-controlled analgesia (IV-
PCA), and local anesthetic infusion in the wound or 
extrapleural space as an intercostal nerve block (6). Several 
studies have compared the effectiveness of these pain 
control options, but no gold standard for pain control 
after thoracic surgery has been established, especially for 
thoracoscopic surgery.
Typically, IV-PCA is used after thoracoscopic surgery, 
but it has side effects that include dizziness, nausea and 
vomiting due to the systemic effects of analgesics (7). The 
subpleural continuous infusion of local anesthesia (ON-
Q system; Kimberly-Clark, Atlanta, GA, USA) can apply 
analgesics locally along the intercostal nerves without 
systemic effects. We hypothesized that the ON-Q system 
would control pain effectively compared with IV-PCA, with 
minimal side effects. Therefore, this retrospective study 
compared the effectiveness and side effects of the ON-Q 
system and IV-PCA in patients undergoing thoracoscopic 
pulmonary resection for primary lung cancer.
Methods
This study was approved by the Institutional Review Board 
of our institution (IRB-No.: AJIRB-MED-MDB-15-446). 
We retrospectively reviewed 66 patients who underwent 
thoracoscopic pulmonary resection for primary lung cancer 
in Ajou University Hospital (Suwon, Korea) from January 
2014 to August 2015. The exclusion criteria were cases of 
thoracotomy conversion, not a primary lung cancer, and 
use of a rib spreader or another pain control method, such 
as thoracic epidural PCA or continuous IV opioid infusion 
without a patient-controlled device. Of the 66 patients, 36 
used IV-PCA and 30 used the ON-Q system.
Surgical methods and catheter placement
All operations were performed under general anesthesia, 
which was typically induced using 1.5–2.0 mg/kg of 
propofol (Fresofol; Fresenius Kabi, Seoul, Korea), 
0.5–1.5 µg/kg of remifentanil (ULTIVA; GlaxoSmithKline, 
Seoul, Korea), and 0.6 mg/kg rocuronium (Rocumeron; 
Ilsung Pharmaceuticals, Seoul, Korea). After inducing 
anesthesia, a double-lumen endotracheal tube was inserted 
for single-lung ventilation during video-assisted thoracic 
surgery (VATS) pulmonary resection and a radial arterial line 
and central venous catheter were placed in the appropriate 
locations. Anesthesia was maintained using sevoflurane 
(1–2 minimal alveolar concentration) and remifentanil 
(0.1–0.3 µg/kg/min) in 50% oxygen and air. The tidal 
volume during single-lung ventilation was 6 mL/kg 
with 100% oxygen. The patient was positioned in the 
lateral decubitus position with the affected side up and the 
skin was prepared preoperatively with 10.0% povidone 
iodine topical solution. The utility port was made in the 4th 
intercostal space (ICS) for upper lobe or right middle lobe 
resection and in the 5th ICS for lower lobe resection. Two 
10-mm trocar ports were made below the 2nd and 3rd ICS 
as utility windows for the thoracoscope and surgical device. 
All operations were performed by a single surgeon using the 
same technique. After performing the pulmonary resection, 
the mediastinal lymph nodes were dissected completely.
Fentanyl citrate (Fentanyl; Hana, Seoul, Korea) and an 
antiemetic (Nasea, ramosetron HCl; Astellas, Seoul, Korea) 
were used for IV-PCA (AutoMed 3200, Ace Medical, 
Seoul, Korea) using 100 mL of normal saline containing 
1,000 µg fentanyl and antiemetic; the basal continuous 
infusion rate was 2 mL/h, and the bolus PCA dose was 
2 mL. The ON-Q system catheter, which has several side 
holes for infusion, was placed in the extrapleural space. It 
was typically placed from the 9th to the 3rd ICS alongside the 
thoracic sympathetic chain to cover all of the VATS incisions 
(Figure 1). The ON-Q system was filled with 250 mL 
of 0.6% ropivacaine (Rocaine, Reyon Pharmaceuticals, 
Seoul, Korea) and the continuous infusion rate was 
4 mL/h. If pleural adhesions were identified or there was 
notable pleural damage during the thoracoscopic lobectomy, 
IV-PCA was used instead of the ON-Q system.
Figure 1 The placement of the subpleural continuous infusion of 
local anesthetic (ON-Q system) catheter in the subpleural space 
from the level below the lowest trocar port [the 9th ICS] to the 
level above the utility window (the 3rd ICS). ICS, intercostal space.
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Assessment of pain
Pain was assessed using a numeric pain intensity scale 
(NPIS). The score was recorded by nurses every 8 hours 
and after interventions for pain control with IV analgesia (8). 
The highest NPIS score from the day of surgery to the day 
of discharge, number of additional IV analgesic injections, 
side effects associated with IV-PCA or the ON-Q system, 
and early discontinuation of pain control devices due to 
side effects were abstracted from the medical records of all 
patients. Early discontinuation was defined as suspension 
of the infusion using pain control devices before complete 
infusion of the initial amount of fluid. This usually meant 
suspending the infusion using pain control devices before 
the second postoperative day.
Statistical methods
Statistical analysis was performed using SPSS for Windows 
software (ver. 20.0; IBM Corp., Somers, NY, USA). The 
patients’ general characteristics and pain scores are provided 
as means ± standard deviation for continuous variables, and 
as the number of cases with frequencies (%) for categorical 
variables. The groups were compared using the chi-
square test or Fisher’s exact test for discrete variables and 
independent samples t-test for continuous variables. The 
highest NPIS scores on each postoperative day in the two 
groups were compared using repeated measures analysis 
of variance (ANOVA). A P value less than 0.05 indicated 
statistical significance.
Results
General characteristics
The general characteristics of the patients are summarized 
in Table 1. The mean age was 63.08±10.47 and 61.30±10.78 
years in the IV-PCA and ON-Q groups, respectively 
(P=0.499). There were 26 (72.2%) and 19 (63.3%) 
males in the IV-PCA and ON-Q groups, respectively 
(P=0.440). To treat the primary lung cancer, we performed 
57 (86.3%) lobectomies, 4 (6.1%) bilobectomies, and 5 
(7.6%) segmentectomies. The right upper lobe was the 
most common location of the lesions in this study (21/66, 
31.8%), followed by the left upper lobe. The preoperative 
lung functions did not differ between the two groups, 
including the forced expiratory volume in 1 second 
Table 1 General characteristics of patients
Variables IV-PCA (n=36) On-Q (n=30) P value
Age (year-old) 63.08±10.47 61.30±10.78 0.499
Gender (male, %) 26 (72.2%) 19 (63.3%) 0.440
Operation 0.466
Lobectomy 32 (88.9%) 25 (83.3%)
Bilobectomy 1 (2.8%) 3 (10.0%)
Segmentectomy 3 (8.3%) 2 (6.7%)
Location of lesion 0.581
Right upper lobe 11 (30.5%) 10 (33.4%)
Right middle lobe 1 (2.8%) 1 (3.3%)
Right lower lobe 9 (25.0%) 7 (23.3%)
Left upper lobe 13 (36.1%) 7 (23.3%)
Left lower lobe 2 (5.6%) 5 (16.7%)
Pre-operative lung function
FEV1% predictable 
(%)
92.88±13.41 92.14±14.09 0.833
FVC% predictable 
(%)
91.48±11.53 93.52±13.76 0.529
FEV1/FVC 101.24±8.47 98.86±13.37 0.414
DLCO (%) 81.55±23.84 79.48±18.47 0.717
Postoperative 
hospital stay (days)
7.89±6.41 7.07±4.27 0.551
Operation time 
(minutes)
113.92±34.09 104.87±19.55 0.203
Blood loss (mL) 143.89±159.11 138.33±136.89 0.881
Pathologic stage 0.286
0 1 (2.8%) 1 (3.3%)
I 22 (61.1%) 21 (70.0%)
II 10 (27.8%) 3 (10.0%)
III 3 (8.3%) 5 (16.7%)
Cell type 0.795
Adenocarcinoma 25 (69.4%) 19 (63.3%)
Squamous cell 
carcinoma
6 (16.7%) 5 (16.7%)
Others 5 (13.9%) 6 (20.0%)
IV-PCA, intravenous patient-controlled analgesia; FEV1, forced 
expiratory volume in 1 second; FVC, forced residual capacity.
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(FEV1), forced residual capacity (FVC), FEV1/FVC (%), 
and diffusing capacity of the lungs for carbon monoxide 
(DLCO). There was no difference between the groups 
in terms of the postoperative hospital stay (7.89±6.41 vs. 
7.07±4.27 days; P=0.551), operating time (113.92±34.09 
vs. 104.87±19.55 min; P=0.203), blood loss during the 
operation (143.89±159.11 vs. 138.33±136.89 mL; P=0.881), 
pathological stage (P=0.286), or cell type (P=0.795) (Table 1).
Pain control
The highest NPIS scores with or without each pain control 
device and the number of additional IV analgesic injections 
did not differ between the two groups. The average highest 
daily NPIS scores after VATS from the day of surgery to 
postoperative day 2 in the IV-PCA group were 4.75±2.35, 
3.11±1.35, and 3.22±1.15, respectively, and those in the 
ON-Q group were 5.27±1.87, 3.83±1.80, and 3.40±1.38, 
respectively. Repeated-measures ANOVA showed that 
NPIS scores decreased gradually with time (P<0.001), but 
there were differences in the patterns of the NPIS scores 
between the two groups (P=0.111, Figure 2), with P values 
of 0.334, 0.067, and 0.570, respectively (independent 
sample t-test). There were 0.72±0.94 additional IV analgesic 
injections in the IV-PCA group and 0.83±0.65 in the ON-Q 
group (P=0.587) from the operation day to the second 
postoperative day.
Side effects and discontinuations
Side effects are summarized in Table 2 and were noted in 13 
of 36 (36.1%) IV-PCA patients and 3 of 30 (10.0%) ON-Q 
patients. The rate of side effects was significantly higher 
in the IV-PCA group (P=0.020). The most frequent side 
effect of IV-PCA was nausea on the day of surgery, which 
was usually accompanied by dizziness or drowsiness. In the 
ON-Q group, there was one case each of nausea, dizziness, 
and drowsiness (Table 2). Early discontinuation of the pain 
control device was required for 12 (33.3%) patients in the 
IV-PCA group versus 2 (6.7%) in the ON-Q group, and the 
difference was significant (P=0.014). Nausea was the main 
cause of early discontinuation of the pain control device in 
the IV-PCA group, while two patients in the ON-Q group 
discontinued pain control because of drowsiness and nausea 
(Table 2). The side effects disappeared after discontinuing 
the pain control devices. There was no catheter-related 
infection in any patient.
Discussion
Pain control after thoracic surgery is important for 
postoperative recovery. Postoperative pain can reduce 
bronchial clearance and is associated with mucous 
plugging, hypoxia, atelectasis, and pulmonary infection (6). 
Effective control of postoperative pain can lead to a better 
postoperative outcome after thoracoscopic pulmonary 
resection. In addition, proper pain control can prevent 
chronic post-thoracotomy pain syndrome (9). There 
are several options for analgesia after thoracic surgery, 
including thoracic epidural anesthesia, thoracic paravertebral 
blockade, IV-PCA, local anesthetic infusion in the wound or 
extrapleural space, and combinations of these methods (6,10). 
Epidural PCA has proven to be effective for pain control 
(6,11,12), but thoracic epidural catheterization has risks of 
dural puncture, epidural hematoma formation, nerve damage, 
hypotension, and unsuccessful catheter placement (7). The 
catheterization also takes time and the success rate usually 
Figure 2 The changes of the highest NPIS scores according to the 
postoperative days. NPIS, numeric pain intensity scale.
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Table 2 Side effects and cause of early discontinuation
Events IV-PCA (n=36) ON-Q (n=30) P
Side effects
Nausea 6 (16.7%) 1 (3.4%) 0.116
Dizziness 4 (11.1%) 1 (3.3%) 0.366
Drowsiness 3 (8.3%) 1 (3.3%) 0.620
Total 13 (36.1%) 3 (10.0%) 0.020
Early discontinuation 12 (33.3%) 2 (6.7%) 0.014
IV-PCA, intravenous patient-controlled analgesia.
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depends on operator experience. Compared with epidural 
PCA, IV-PCA can be applied easily with fewer procedure-
related complications and equivalent efficacy (7). However, 
IV-PCA administers analgesics via a systemic route, which 
can result in side effects such as dizziness, somnolence, 
pruritus, nausea and vomiting, even when delivered with a 
PCA system (7). In our series, the incidence of side effects 
in the IV-PCA group was 36.1%, and most patients who 
developed side effects in the IV-PCA group could not 
maintain the pain control device because of the side effects 
(12/13, 92.3%), although all of the side effects subsided after 
stopping IV-PCA. We believe that these systemic side effects 
originated from the type of infusion agent and route of 
infusion. Therefore, we sought another pain control system 
as an alternative to IV-PCA.
Some studies reported notable pain control with the 
subpleural injection of local anesthetics (10,13), while 
other studies found this to be less effective (12,14). 
Local anesthetics such as bupivacaine, which is similar 
to ropivacaine, have shorter analgesic durations (10), so 
they require continuous infusion postoperatively to be 
effective. We hypothesized that the continuous infusion of 
local anesthetics along the intercostal nerve would reduce 
the postoperative pain. Compared with IV-PCA, our data 
showed that the ON-Q system resulted in equivalent pain 
control with fewer side effects compared with systemic 
analgesics. The ON-Q pain control system continuously 
infused 0.6% ropivacaine at 4 mL/h. The total volume of 
the chamber is 250 mL, enabling pain control for up to 
60 hours. The ON-Q system can provide sufficient 
analgesia in the immediate postoperative period because the 
NPIS score postoperatively is usually highest on the day of 
surgery and decreases gradually over time (11). Our results 
are supported by previous reports; Ried et al. (1) compared 
the ON-Q system and thoracic epidural analgesia after 
thoracic surgery and reported effective pain control after 
thoracotomy with the ON-Q system.
When inserting the On-Q system catheter, several 
precautions are required. The operator needs to make a 
careful approach to prevent pleural tearing during catheter 
and sheath placement. If the pleura are injured during the 
procedure, the local anesthetics will leak into the pleural 
cavity, which may lead to an insufficient analgesic effect. 
We used a blunt-end tunneler to prevent pleural injury, and 
achieved direct visualization during the procedure using a 
thoracoscope. If there were severe inter-pleural adhesions, 
massive inter-pleural adhesiolysis was performed during 
VATS pulmonary resection; in cases of significant pleural 
damage, especially to the costal pleura due to any operative 
or patient-related factors, we felt that the On-Q system was 
inappropriate. The On-Q system catheter should cover all 
intercostal levels that were used for operative incisions for 
the VATS pulmonary resection. Finally, the On-Q system 
should be avoided in patients with a significant bleeding 
tendency.
This study had several limitations. First, it was a 
retrospective study and the assignment of the pain control 
device to each patient was not randomized, resulting in 
selection bias. IV-PCA was performed mainly in patients 
with pleural adhesions or incidental injury of the parietal 
pleura during the operation. Second, the study had a 
relatively small number of cases. Third, the additional 
IV injection for analgesia was not standardized and the 
potency of the pain control differed with the drugs used. 
The additional intervention for pain control was measured 
according to the number of injections because we could not 
quantify each IV agent. Despite these limitations, our study 
is the first to compare IV-PCA and the ON-Q system in the 
context of thoracoscopic surgery only. Unlike other studies, 
the consistency of patients is an advantage of our study. 
Previous studies enrolled patients who underwent different 
surgical procedures, such as lobectomy, wedge resection, 
or pleurodesis (11). We limited the study group to patients 
with primary lung cancer who underwent thoracoscopic 
pulmonary resections, and a single surgeon performed all 
of the operations using a standard operative technique. 
A randomized prospective study of various pain-control 
devices after thoracoscopic surgery should be performed to 
improve postoperative pain control.
In conclusion, the efficacy of the ON-Q system was 
equivalent to IV-PCA in postoperative pain control after 
thoracoscopic pulmonary resection for primary lung cancer, 
with fewer side effects and less early discontinuation.
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